Progressive dilation of the aortic root is considered one of the most serious manifestations of Marfan syndrome because it can lead to aortic dissection and death. Pharmacotherapy is used to attenuate the progression of this ...
Feb 9, 2018
0
5
(HealthDay)—For patients with hypertension and obstructive sleep apnea (OSA), treatment with losartan does not lead to significant reductions in aldosterone, but the treatment is tied to aldosterone reductions in patients ...
Sep 9, 2016
0
0
A common drug that is used to treat high blood pressure in the general population has been found to significantly reduce a dangerous and frequently fatal cardiac problem in patients with Marfan syndrome.
Sep 2, 2013
0
0
Two drugs, telmisartan and valsartan, which are used to reduce blood pressure in people with diabetes, are associated with a lower risk of hospitalization for heart attack, stroke or heart failure, according to a study published ...
Jul 8, 2013
0
0
A ground-breaking trial that hopes to discover if a drug commonly used to treat high blood pressure could slow down the progression of Alzheimer's disease (AD) will begin shortly.
Mar 4, 2013
0
0
(HealthDay) -- Black patients with hypertension face a significantly increased risk of sudden cardiac death (SCD) compared with nonblack patients, even after adjusting for multiple confounding variables, according to a study ...
Apr 13, 2012
0
0
Although observational studies have suggested that losartan, a drug used primarily for the treatment of hypertension, may be associated with an increased risk of death among patients with heart failure compared with other ...
Apr 10, 2012
0
0
Using geriatric mice, a Johns Hopkins research team has shown that losartan, a commonly used blood pressure drug, not only improves regeneration of injured muscle but also protects against its wasting away from inactivity.
May 11, 2011
0
0
Administration of losartan to hospitalized patients with COVID-19 and acute lung injury is not efficacious for reducing lung injury, according to a study published online March 16 in JAMA Network Open.
Mar 16, 2022
0
49
The recall of the commonly prescribed blood pressure drug losartan has been expanded once again to include an additional five lots.
Sep 25, 2019
0
5
